Sculptor Capital’s CONMED CNMD Stock Holding History

Sculptor Capital’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-5,040	Closed	-$483K	–	1095
2022 Q2	$483K	Buy	+5,040	New	+$605K	0.01%	672

Other funds holding CNMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Sculptor Capital's CNMD Position: Q3 2022 in Review

Sculptor Capital sold out of CONMED (CNMD) in Q3 2022, closing a stake of 5,040 shares — an estimated $483K sold.

Sculptor Capital first reported a position in CNMD in Q2 2022 and held it in 1 quarter. The position peaked at $483K in Q2 2022. 252 funds tracked by Wall St. Rank hold CNMD as of Q3 2022.

Sculptor Capital reported no remaining CONMED position as of Q3 2022 after selling out during the quarter.
Sculptor Capital sold 5,040 CONMED shares in Q3 2022, an estimated $483K.
Sculptor Capital first reported a position in CONMED in Q2 2022 and held it in 1 quarter.
Sculptor Capital's CONMED position peaked at $483K in Q2 2022.
252 funds tracked by Wall St. Rank held CONMED as of Q3 2022.

Based on Sculptor Capital's 13F filing for Q3 2022, filed 14 Nov 2022.